Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 698 43 070.0 |
| 96 | EP file number | EAKZ | 10 18 2575.0 |
| 97 | EP publication number | EPN | 2305282 |
| 54 | Designation/title | TI | Vorbeugung und Behandlung von amyloidogener Krankheit |
| 51 | IPC main class | ICM
(ICMV) | A61K 38/00 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 38/28 (2006.01), A61K 9/26 (2006.01), A61K 33/06 (2006.01) |
| 22 | DE application date | DAT | Nov 30, 1998 |
| 96 | EP application date | EAT | Nov 30, 1998 |
| 43 | Date of first publication | OT | Apr 6, 2011 |
| Date of publication of grant | PET | Jul 10, 2013 |
| 71/73 | Applicant/owner | INH | Janssen Alzheimer Immunotherapy, Dublin, IE |
| 72 | Inventor | IN | Schenk, Dale B., Burlingame, CA 94010, US |
| 74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
67740 P
Dec 2, 1997
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
80970 P
Apr 7, 1998
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000002305282
Searchable text:
EP000002305282
Original document:
EP000002305282B1
Searchable text:
EP000002305282B1 |
| 43 | Date of first publication | EVT | Apr 6, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 30, 2022
(Show all update days)(Hide all update days)- May 26, 2011
- Date of the first transfer into DPMAregister
|
